OPGN (OpGen Corporation) Earnings per share growth rate in current year

OpGen, Inc. (OPGN) has developed an infection control system that integrates molecular diagnostics with resistance data. Annual EPS growth peaked before declining, and the 0.00 level now serves as a critical benchmark. Management is currently facing a profound crisis of confidence due to a failed strategy, while the implementation of digital microbiology platforms in clinics is yielding moderate results as the company awaits new licensing contracts.

opgen.com (OPGN): Net earnings per share growth this year from 07/04/2022 to 08/31/2024

Analytical breakdowns and data insights for company OpGen, Inc. (OPGN)

- current price and projected stock value:

Quote Chart OpGen Inc|OPGN - Analyst Consensus Forecast

- business market valuation indicators:

Market Value OpGen Corporation|OPGN - Enterprise Value

- balance sheet equity data:

Accounting Value per Share OpGen|OPGN - Company Net Assets|Market Cap to Book Value Multiple opgen.com|OPGN - Company Total Assets

- debt burden and liquidity indicators:

- net income and valuation ratios data:

OPGN - Company Net Income|Forward Earnings OpGen, Inc.|OPGN - P/E Multiple|Forward Price to Earnings Multiple OpGen Corporation|OPGN - PEG Multiple|Company Value to EBITDA OpGen Corporation|OPGN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months OpGen|OPGN - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months opgen.com|OPGN - Earnings growth in current year|Consensus forecast of earnings per share growth for next year OpGen, Inc.

- company sales and revenue statistics:

OPGN - Company Revenue|Company Revenue Forecast OpGen Inc|OPGN - P/S Multiple|Forward Price-to-Revenue Multiple OpGen Corporation

Basic company analysis:OpGen Inc

This indicator measures the year-over-year earnings per share (EPS) dynamics for OpGen, Inc. (OPGN), reflecting the efficiency of net income generation relative to the cost of capital. By analyzing the EPS comparison with the previous year, an investor assesses how the implementation of diagnostic systems in hospitals converts into actual financial results. Steady growth in this metric confirms the scalability of the business model and the company's resilience to operating expenses.

Main competitors